Physician profile
Joseph Cali
NPI 1871504225
$3,701.43
in general payments reported to CMS, 2019-2025
20 companies · $857 in 2025
The $857 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $814 · 2020: $178 · 2021: $239 · 2022: $392 · 2023: $578 · 2024: $644 · 2025: $857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,078.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $424.37 | 2024-2025 | Perclot, Tisseel |
| Pacira Pharmaceuticals Incorporated | $396.33 | 2019-2025 | Exparel, Iovera |
| Thd America, INC. | $382.21 | 2022-2025 | |
| Intuitive Surgical, INC. | $333.26 | 2020-2025 | |
| Ethicon US, LLC | $287.18 | 2019-2024 | Echelon Flex, Ethicon, Evarrest |
| Edwards Lifesciences Corporation | $249.12 | 2019-2021 | |
| Becton, Dickinson and Company | $202.24 | 2024 | Hemosphere |
| Medtronic, INC. | $192.58 | 2023 | Signia, Surgipro Ll, Gi Genius |
| Aroa Biosurgery Incorporated | $167.05 | 2025 | |
| Allergan, INC. | $155.14 | 2019-2020 | |
| Romark Laboratories, Lc | $145.41 | 2019 | |
| Davol INC. | $139.66 | 2023 | Arista Ah Flexitip |
| Vertex Pharmaceuticals Incorporated | $109.82 | 2025 | |
| Stryker Corporation | $105.99 | 2019 | |
| Shire North American Group INC | $105.79 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $105.20 | 2022 | |
| Tela Bio, INC. | $93.34 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Covidien LP | $74.50 | 2020 | |
| Novo Nordisk INC | $17.68 | 2024 | Ozempic, Rybelsus |
| Procept Biorobotics Corporation | $14.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.